Oventus partners with Aeroflow on oral therapy

 - 
Tuesday, February 25, 2020

BRISBANE, Australia – Oventus Medical has announced that its oral devices to treat obstructive sleep apnea will now be sold by Aeroflow Healthcare.

Per an agreement, Oventus’ devices and consumables, including its O2Vent Optima, will be introduced by Aeroflow throughout its locations and direct-to-consumer platform, as well as through agreements with referring sleep clinics across the southeastern U.S.

“Oventus and Aeroflow are aligned through our growth targets and shared interest in providing the best available care to patients,” said Dr. Chris Hart, CEO of Oventus. “This agreement will see Oventus products rolled out initially across the Southeast and then nationally as part of Aeroflow’s U.S. expansion plans.”

In addition, Aeroflow will offer Oventus products under subcontracts with regional sleep groups nationwide.